Rights statement: ACS Author Choice CCA-BY
Final published version, 2.7 MB, PDF document
Available under license: CC BY
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei.
AU - Urbaniak, Mick
AU - Collie, Iain T.
AU - Fang, Wenxia
AU - Aristotelous, Tonia
AU - Eskilsson, Susanne
AU - Raimi, Olwale G.
AU - Harrison, Justin
AU - Hopkins Navratilova, Iva
AU - Frearson, Julie A.
AU - van Aalten, Daan M. F.
AU - Ferguson, Michael A J
N1 - ACS Author Choice CCA-BY
PY - 2013/9/20
Y1 - 2013/9/20
N2 - Uridine diphosphate N-acetylglucosamine pyrophosphorylase (UAP) catalyzes the final reaction in the biosynthesis of UDP-GlcNAc, an essential metabolite in manyorganisms including Trypanosoma brucei, the etiological agent of Human African Trypanosomiasis. High-throughput screening of recombinant T. brucei UAP identified a UTP-competitive inhibitor with selectivity over the human counterpart despite the high level of conservation of active site residues. Biophysical characterization of the UAP enzyme kinetics revealed that the human and trypanosome enzymes both display a strictly ordered bi−bi mechanism, but withthe order of substrate binding reversed. Structural characterization of the T. brucei UAP−inhibitor complex revealed that the inhibitor binds at an allosteric site absent in the human homologue that prevents the conformational rearrangement required to bind UTP.The identification of a selective inhibitory allosteric binding site in the parasite enzyme has therapeutic potential.
AB - Uridine diphosphate N-acetylglucosamine pyrophosphorylase (UAP) catalyzes the final reaction in the biosynthesis of UDP-GlcNAc, an essential metabolite in manyorganisms including Trypanosoma brucei, the etiological agent of Human African Trypanosomiasis. High-throughput screening of recombinant T. brucei UAP identified a UTP-competitive inhibitor with selectivity over the human counterpart despite the high level of conservation of active site residues. Biophysical characterization of the UAP enzyme kinetics revealed that the human and trypanosome enzymes both display a strictly ordered bi−bi mechanism, but withthe order of substrate binding reversed. Structural characterization of the T. brucei UAP−inhibitor complex revealed that the inhibitor binds at an allosteric site absent in the human homologue that prevents the conformational rearrangement required to bind UTP.The identification of a selective inhibitory allosteric binding site in the parasite enzyme has therapeutic potential.
U2 - 10.1021/cb400411x
DO - 10.1021/cb400411x
M3 - Journal article
VL - 8
SP - 1981
EP - 1987
JO - ACS Chemical Biology
JF - ACS Chemical Biology
SN - 1554-8929
IS - 9
ER -